21.20.Z - Manufacture of medicines and other pharmaceutical products
10.86.Z - Manufacture of homogenised food preparations and dietetic food
10.89.Z - Manufacture of other food products not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical substances
46.46.Z - Wholesale of pharmaceutical goods
82.92.Z - Packaging activities
2019 | 2020 | 2021 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets | 10,1 | 10,2 | 10,9 | 6,3 |
Profit (loss) on sale | 0,5 | -0,1 | 0,4 | 570,9 |
Gross profit (loss) | 0,2 | -1,3 | -0,1 | 94,6 |
Net profit (loss) | 0,2 | -1,3 | -0,1 | 94,6 |
Cash | 0,1 | 0,2 | 0,1 | -31,8 |
Net income from sale | 3,8 | 2,8 | 5,1 | 83,1 |
Liabilities and provisions for liabilities | 11,7 | 13,1 | 13,9 | 6 |
Short time liabilities | 1,1 | 1 | 1,5 | 45,8 |
Other operating costs | 0 | 0 | 0,1 | 771 |
Current financial liquidity indicator | 0 | 0 | 0 | -8,7 |
Equity capital | -1,6 | -2,9 | -3 | -5,1 |
Working assets | 2 | 2,3 | 3,2 | 35,5 |
Other operating income | 0 | 0 | 0 | -99,8 |
Operating profit (EBIT) | 0,5 | -0,1 | 0,3 | 474,5 |
% | % | % | p.p. | |
Profitability of capital | -14,3 | 44,5 | 2,3 | -42,2 |
Equity capital to total assets | -15,8 | -28,3 | -28 | 0,3 |
Gross profit margin | 6 | -46,5 | -1,4 | 45,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 104 | 136 | 108 | -28 |
Opinions regarding services, products, and company activities are not verified. This means that ING Services for Business S.A., as the provider of the Aleo platform, does not ensure that the published opinions come from consumers who have used the product or availed of the company's services. However, we do strive to ensure that opinions do not violate universally applicable laws.